Technology | January 05, 2011

AngioScore Expands Recall of Scoring Balloons

December 5, 2010 – Additional lots lots of the AngioSculpt Percutaneous Transluminal Angioplasty (PTA) Scoring Balloon Catheters are being recalled by the AngioScore Inc. The class I recall was originally initiated in December 2009, but the FDA reissued the alert in September. It was expanded this week to newer catheters produced between September 2007 and November 2010, which includes 17,682 units.

The U.S. Food and Drug Administration (FDA) said a design defect may cause unintended fracture and peeling, which has resulted in peeling of the bond and/or detachment of the distal end of the scoring element. Use of affected devices may lead to retained device fragments or significant arterial injury, which may lead to death or need for additional surgical intervention.

The new recall includes the AngioSculpt PTA Scoring Balloon Catheter, OTW 0.018" platform in multiple sizes. The following model part (REF) numbers and includes all sizes and lot codes for each model listed:
• 2076-4020
• 2076-5020
• 2076-6020
• 2092-6020
• 2105-6020
AngioScore Inc. sent Medical Device Recall notification letters to all domestic customers on Nov. 15 by overnight mail. The recall letters list the affected product with description, part numbers and that all lots are affected. They describe the reason for recall and the potential harm to patients.

The AngioSculpt PTA Scoring Balloon Catheter, OTW 0.018" platform is used for dilatation of lesions in the iliac, femoral, ilia-femoral, popliteal, infra-popliteal, and renal arteries, and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae.

The original recall included the AngioSculpt EX PTCA scoring balloon catheters used to dilate narrowed coronary arteries and to improve myocardial perfusion. Those affected catheters included all part/REF numbers 2034-XXYY with lot numbers less than F09060003.

Class 1 recalls are the most serious type of recall and involve situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death.

For more information, contact AngioScore customer service at 877.264.4692.

For more information: www.fda.gov

Related Content

Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Medtronic Announces Japanese Regulatory Approval for In.Pact Admiral Drug-Coated Balloon
News | Drug-Eluting Balloons| September 13, 2017
Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from the Japanese Ministry...
Lutonix 035 Drug Coated Balloon Earns Additional FDA Premarket Approval
Technology | Drug-Eluting Balloons| August 29, 2017
C.R. Bard Inc. announced the Lutonix 035 Drug Coated Balloon PTA Catheter (DCB) has been granted premarket approval (...
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
Spectranetics Announces FDA Approval of Stellarex Drug-Coated Balloon
Technology | Drug-Eluting Balloons| July 26, 2017
The Spectranetics Corp. announced receipt of U.S. Food and Drug Administration (FDA) pre-market approval (PMA) of the...
News | June 12, 2017
June 12, 2017 – Med Alliance announced completion on schedule of patient enrollment in the first-in-man (FIM) study o
Abbott recalls its NC Balloon catheters
News | Balloon Catheter| May 22, 2017
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports
Sponsored Content | Videos | EP Lab| May 17, 2017
This video, provided by Spectranetics, demonstrates how to deploy the Bridge Occlusion Balloon used to seal accidenta
Contego Medical Receives CE Mark for Vanguard IEP Peripheral Balloon Angioplasty System
News | Peripheral Artery Disease (PAD)| May 17, 2017
Contego Medical LLC announced recently that it has received CE Marking of its Vanguard IEP Peripheral Balloon...
Overlay Init